Woodard Jr Joseph Paul 4
4 · BELLICUM PHARMACEUTICALS, INC · Filed Nov 14, 2019
Insider Transaction Report
Form 4
Woodard Jr Joseph Paul
SVP Clinical & Medical Affairs
Transactions
- Tax Payment
Common Stock
2019-11-13$0.82/sh−1,597$1,310→ 5,467 total - Exercise/Conversion
Common Stock
2019-11-13+3,750→ 7,064 total - Exercise/Conversion
Restricted Stock Units
2019-11-13−3,750→ 7,500 total→ Common Stock (3,750 underlying)
Footnotes (4)
- [F1]Each Restricted Stock Unit (the "RSU") represents a contingent right to receive one share of BLCM common stock.
- [F2]Includes 899 shares acquired by the reporting person under the Issuer's Employee Stock Purchase Plan.
- [F3]Represents the number of shares withheld by and surrendered to the Issuer on November 13, 2019, to satisfy tax withholding obligations that arose in connection with the vesting of the RSUs granted to the reporting person on November 13, 2017 for 15,000 shares.
- [F4]On November 13, 2017, the reporting person was granted 15,000 RSUs, of which 3,750 vested on November 13, 2019. The RSUs vest in four annual installments beginning November 13, 2018.